Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1990 March 1; 171(3): 729–743.
PMCID: PMC2187769

Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes


Essential fatty acid (EFA) deficiency exerts a striking protective effect in several animal models of autoimmune disease. We now report that EFA deprivation prevents diabetes in the BB rat, an animal model of human insulin-dependent diabetes mellitus. In diabetes-prone (DP)-BB rats, the incidences of spontaneous diabetes and insulitis (the pathological substrate of autoimmune diabetes) were greatly reduced by EFA deficiency. This beneficial effect of the deficiency state was also seen in diabetes-resistant (DR)-BB rats that, after treatment with antibody to eliminate RT6+ T cells, would otherwise have become diabetic. The susceptibility of EFA-deprived DP-BB rats to spontaneous diabetes was restored when they were given dietary supplements of linoleate at 70 d of age (during the usual period of susceptibility), but not when they were repleted beginning at 120 d (after the peak incidence of diabetes). EFA deficiency did lead to growth retardation, but calorically restricted control rats demonstrated that the protective effect of the deficiency state was not a function of decreased weight. To examine the relationship between the biochemical changes of EFA deficiency and its physiological effects in this system, we compared the fatty acid changes that occurred in EFA-deficient animals that did and did not develop diabetes. Nondiabetic animals had significantly lower levels of (n-6) fatty acids (i.e., linoleate and arachidonate) and higher levels of oleate, an (n-9) fatty acid, than did diabetic animals. Levels of 20:3(n-9), the fatty acid that uniquely characterizes EFA deficiency, were similar in both groups, however. Among diabetic EFA-deficient rats, the age at onset of diabetes was found to correlate inversely with the level of (n-6) fatty acids, the least depleted animals becoming diabetic earliest, whereas there was no correlation with levels of 20:3(n-9). Among animals repleted with linoleate beginning at 70 d, restoration of susceptibility to diabetes correlated with normalization of the level of arachidonate. In summary, EFA deprivation reduced the frequency of diabetes in both DP and RT6- depleted DR-BB rats. This protective effect was strongly associated with depletion of (n-6) fatty acids, particularly arachidonate, but not with accumulation of the abnormal 20:3(n-9). Conjecturally, arachidonate and/or a metabolite may play a key role in mediating inflammatory injury in this animal model of autoimmune diabetes.

Full Text

The Full Text of this article is available as a PDF (1003K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hurd ER, Johnston JM, Okita JR, MacDonald PC, Ziff M, Gilliam JW. Prevention of glomerulonephritis and prolonged survival in New Zealand Black/New Zealand White F1 hybrid mice fed an essential fatty acid-deficient diet. J Clin Invest. 1981 Feb;67(2):476–485. [PMC free article] [PubMed]
  • Schreiner GF, Rovin B, Lefkowith JB. The antiinflammatory effects of essential fatty acid deficiency in experimental glomerulonephritis. The modulation of macrophage migration and eicosanoid metabolism. J Immunol. 1989 Nov 15;143(10):3192–3199. [PubMed]
  • Spaethe SM, Freed MS, De Schryver-Kecskemeti K, Lefkowith JB, Needleman P. Essential fatty acid deficiency reduces the inflammatory cell invasion in rabbit hydronephrosis resulting in suppression of the exaggerated eicosanoid production. J Pharmacol Exp Ther. 1988 Jun;245(3):1088–1094. [PubMed]
  • Wright JR, Jr, Lefkowith JB, Schreiner G, Lacy PE. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice. Proc Natl Acad Sci U S A. 1988 Aug;85(16):6137–6141. [PubMed]
  • Parfrey NA, Prud'homme GJ, Colle E, Fuks A, Seemayer TA, Guttmann RD, Ono SJ. Immunologic and genetic studies of diabetes in the BB rat. Crit Rev Immunol. 1989;9(1):45–65. [PubMed]
  • Mordes JP, Desemone J, Rossini AA. The BB rat. Diabetes Metab Rev. 1987 Jul;3(3):725–750. [PubMed]
  • Like AA, Appel MC, Rossini AA. Autoantibodies in the BB/W rat. Diabetes. 1982 Sep;31(9):816–820. [PubMed]
  • Koevary S, Rossini A, Stoller W, Chick W, Williams RM. Passive transfer of diabetes in the BB/W rat. Science. 1983 May 13;220(4598):727–728. [PubMed]
  • Koevary SB, Williams DE, Williams RM, Chick WL. Passive transfer of diabetes from BB/W to Wistar-Furth rats. J Clin Invest. 1985 Jun;75(6):1904–1907. [PMC free article] [PubMed]
  • Elder ME, Maclaren NK. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol. 1983 Apr;130(4):1723–1731. [PubMed]
  • Woda BA, Padden C. BioBreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells. J Immunol. 1987 Sep 1;139(5):1514–1517. [PubMed]
  • Greiner DL, Handler ES, Nakano K, Mordes JP, Rossini AA. Absence of the RT-6 T cell subset in diabetes-prone BB/W rats. J Immunol. 1986 Jan;136(1):148–151. [PubMed]
  • Laupacis A, Stiller CR, Gardell C, Keown P, Dupre J, Wallace AC, Thibert P. Cyclosporin prevents diabetes in BB Wistar rats. Lancet. 1983 Jan 1;1(8314-5):10–12. [PubMed]
  • Like AA, Kislauskis E, Williams RR, Rossini AA. Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science. 1982 May 7;216(4546):644–646. [PubMed]
  • Like AA, Anthony M, Guberski DL, Rossini AA. Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes. Diabetes. 1983 Apr;32(4):326–330. [PubMed]
  • Oschilewski U, Kiesel U, Kolb H. Administration of silica prevents diabetes in BB-rats. Diabetes. 1985 Feb;34(2):197–199. [PubMed]
  • Rossini AA, Slavin S, Woda BA, Geisberg M, Like AA, Mordes JP. Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes. 1984 Jun;33(6):543–547. [PubMed]
  • Rossini AA, Faustman D, Woda BA, Like AA, Szymanski I, Mordes JP. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest. 1984 Jul;74(1):39–46. [PMC free article] [PubMed]
  • Burstein D, Mordes JP, Greiner DL, Stein D, Nakamura N, Handler ES, Rossini AA. Prevention of diabetes in BB/Wor rat by single transfusion of spleen cells. Parameters that affect degree of protection. Diabetes. 1989 Jan;38(1):24–30. [PubMed]
  • Butler L, Guberski DL, Like AA. Genetic analysis of the BB/W diabetic rat. Can J Genet Cytol. 1983 Feb;25(1):7–15. [PubMed]
  • Like AA, Guberski DL, Butler L. Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic. J Immunol. 1986 May 1;136(9):3254–3258. [PubMed]
  • Greiner DL, Mordes JP, Handler ES, Angelillo M, Nakamura N, Rossini AA. Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. J Exp Med. 1987 Aug 1;166(2):461–475. [PMC free article] [PubMed]
  • Elliott WJ, Morrison AR, Sprecher H, Needleman P. Calcium-dependent oxidation of 5,8,11-icosatrienoic acid by the cyclooxygenase enzyme system. J Biol Chem. 1986 May 25;261(15):6719–6724. [PubMed]
  • Hammarström S. Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. J Biol Chem. 1981 Mar 10;256(5):2275–2279. [PubMed]
  • BLIGH EG, DYER WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. [PubMed]
  • Rossini AA, Williams RM, Mordes JP, Appel MC, Like AA. Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes. 1979 Nov;28(11):1031–1032. [PubMed]
  • Dyrberg T, Schwimmbeck P, Oldstone M. The incidence of diabetes in BB rats is decreased following acute LCMV infection. Adv Exp Med Biol. 1988;246:397–402. [PubMed]
  • Rossini AA, Mordes JP, Gallina DL, Like AA. Hormonal and environmental factors in the pathogenesis of BB rat diabetes. Metabolism. 1983 Jul;32(7 Suppl 1):33–36. [PubMed]
  • Scott FW, Mongeau R, Kardish M, Hatina G, Trick KD, Wojcinski Z. Diet can prevent diabetes in the BB rat. Diabetes. 1985 Oct;34(10):1059–1062. [PubMed]
  • Lefkowith JB, Flippo V, Sprecher H, Needleman P. Paradoxical conservation of cardiac and renal arachidonate content in essential fatty acid deficiency. J Biol Chem. 1985 Dec 15;260(29):15736–15744. [PubMed]
  • Lefkowith JB, Jakschik BA, Stahl P, Needleman P. Metabolic and functional alterations in macrophages induced by essential fatty acid deficiency. J Biol Chem. 1987 May 15;262(14):6668–6675. [PubMed]
  • Yamanaka WK, Clemans GW, Hutchinson ML. Essential fatty acids deficiency in humans. Prog Lipid Res. 1980;19(3-4):187–215. [PubMed]
  • Ramesha CS, Pickett WC. Platelet-activating factor and leukotriene biosynthesis is inhibited in polymorphonuclear leukocytes depleted of arachidonic acid. J Biol Chem. 1986 Jun 15;261(17):7592–7595. [PubMed]
  • Smith MJ, Ford-Hutchinson AW, Bray MA. Leukotriene B: a potential mediator of inflammation. J Pharm Pharmacol. 1980 Jul;32(7):517–518. [PubMed]
  • Valone FH, Goetzl EJ. Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). Am J Pathol. 1983 Oct;113(1):85–89. [PubMed]
  • Lee KU, Pak CY, Amano K, Yoon JW. Prevention of lymphocytic thyroiditis and insulitis in diabetes-prone BB rats by the depletion of macrophages. Diabetologia. 1988 Jun;31(6):400–402. [PubMed]
  • Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy. 1985 Aug;40(6):424–429. [PubMed]
  • Lefkowith JB, Schreiner G. Essential fatty acid deficiency depletes rat glomeruli of resident macrophages and inhibits angiotensin II-induced eicosanoid synthesis. J Clin Invest. 1987 Oct;80(4):947–956. [PMC free article] [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press